Coronavirus disease 2019 infection and the cardiovascular system

J Cardiovasc Med (Hagerstown). 2020 Jun;21(6):403-405. doi: 10.2459/JCM.0000000000000980.

Authors

Francesco Romeo¹, Giuseppe Calcaterra², Francesco Barilla³, Jawahar L Mehta⁴

Affiliations

¹ Department of Cardiology, University of Rome 'Tor Vergata', Rome.
² Postgraduate Medical School, University of Palermo, Palermo.
³ Cardiac Department, Università La Sapienza Rome, Rome, Italy.
⁴ Cardiology Section, VA Medical Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.

PMID: 32324641
DOI: 10.2459/JCM.0000000000000980

No abstract available

Publication types

Editorial

MeSH terms

Antiviral Agents / therapeutic use
Betacoronavirus / drug effects
Betacoronavirus / pathogenicity*
COVID-19
COVID-19 Drug Treatment
Cardiovascular Diseases / diagnosis
Cardiovascular Diseases / drug therapy
Cardiovascular Diseases / physiopathology
Cardiovascular Diseases / virology*
Cardiovascular System / drug effects
Cardiovascular System / physiopathology
Cardiovascular System / virology*
Coronavirus Infections / diagnosis
Coronavirus Infections / drug therapy
Coronavirus Infections / physiopathology
Coronavirus Infections / virology*
Host Microbial Interactions
Humans
Pandemics
Pneumonia, Viral / diagnosis
Pneumonia, Viral / drug therapy
Pneumonia, Viral / physiopathology
Pneumonia, Viral / virology*
Renin-Angiotensin System
SARS-CoV-2

Substances

Antiviral Agents